Brainsway Ltd (BWAY) - Total Assets
Based on the latest financial reports, Brainsway Ltd (BWAY) holds total assets worth ILA113.06 Million ILA (≈ $303.12K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BWAY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Brainsway Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Brainsway Ltd's total assets have evolved over time, based on quarterly financial data. Explore BWAY long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Brainsway Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Brainsway Ltd's total assets of ILA113.06 Million consist of 84.5% current assets and 15.5% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 73.5% |
| Accounts Receivable | ILA4.60 Million | 4.9% |
| Inventory | ILA4.43 Million | 4.7% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Brainsway Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Brainsway Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brainsway Ltd's current assets represent 84.5% of total assets in 2024, a decrease from 93.0% in 2012.
- Cash Position: Cash and equivalents constituted 73.5% of total assets in 2024, up from 40.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 4.9% of total assets.
Brainsway Ltd Competitors by Total Assets
Key competitors of Brainsway Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Brainsway Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.19 | 4.52 | 3.57 |
| Quick Ratio | 3.02 | 4.23 | 3.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA56.94 Million | ILA44.64 Million | ILA17.50 Million |
Brainsway Ltd - Advanced Valuation Insights
This section examines the relationship between Brainsway Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.71 |
| Latest Market Cap to Assets Ratio | 4.59 |
| Asset Growth Rate (YoY) | 49.8% |
| Total Assets | ILA94.32 Million |
| Market Capitalization | $433.31 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Brainsway Ltd's assets at a significant premium (4.59x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Brainsway Ltd's assets grew by 49.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Brainsway Ltd (2012–2024)
The table below shows the annual total assets of Brainsway Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA94.32 Million ≈ $252.86K |
+49.77% |
| 2023-12-31 | ILA62.97 Million ≈ $168.83K |
-2.33% |
| 2022-12-31 | ILA64.48 Million ≈ $172.86K |
-14.86% |
| 2021-12-31 | ILA75.73 Million ≈ $203.03K |
+122.67% |
| 2020-12-31 | ILA34.01 Million ≈ $91.18K |
-12.20% |
| 2019-12-31 | ILA38.74 Million ≈ $103.85K |
+64.12% |
| 2018-12-31 | ILA23.60 Million ≈ $63.28K |
-12.68% |
| 2017-12-31 | ILA27.03 Million ≈ $72.47K |
+35.39% |
| 2016-12-31 | ILA19.96 Million ≈ $53.52K |
-10.25% |
| 2015-12-31 | ILA22.24 Million ≈ $59.63K |
-13.69% |
| 2014-12-31 | ILA25.77 Million ≈ $69.09K |
+44.40% |
| 2013-12-31 | ILA17.85 Million ≈ $47.85K |
+66.98% |
| 2012-12-31 | ILA10.69 Million ≈ $28.65K |
-- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more